Nov 16, 2004 · Abstract. Relapsed AML after allogeneic SCT has a poor prognosis. So far, no standard therapy could be defined. Donor lymphocyte transfusion ...
Relapsed AML after allogeneic SCT has a poor prognosis. So far, no standard therapy could be defined. Donor lymphocyte transfusion (DLT) has been effective ...
Relapsed AML after allogeneic SCT has a poor prognosis. So far, no standard therapy could be defined. Donor lymphocyte transfusion (DLT) has been effective ...
The efficacy of donor lymphocyte infusion (DLI) for acute myeloid leukemia (AML) relapse after allogeneic hematopoietic stem cell transplantation (HSCT) ...
Missing: comparison 489
Oct 1, 2007 · Purpose: To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed acute myeloid leukemia (AML) after allogeneic ...
Missing: 489 | Show results with:489
People also ask
What is the prognosis for AML relapse after stem cell transplant?
What happens if leukemia comes back after stem cell transplant?
What are the odds of relapse after bone marrow transplant?
Is hematopoietic stem cell transplantation for acute myeloid leukemia?
The outcome of patients with acute leukemia (AL) after experiencing relapse after allogeneic hematopoietic stem-cell transplantation (HSCT) is poor. No standard ...
Allogeneic hematopoietic cell transplantation (allo-HCT) offers the chance of cure for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) [1].
Jan 5, 2023 · Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a potentially curative treatment for acute leukemias. However, relapse is the ...
The aim of this study was to retrospectively identify the factors affecting the efficacy of DLI for adult patients with a first hematological relapse after ...
Missing: 489 | Show results with:489
Jul 25, 2023 · Therapeutic donor lymphocyte infusions (tDLI) are used to reinforce the graft-versus-leukemia (GvL) effect in relapse after allogeneic stem cell ...